B.C. funding rapid access treatment, public safety to address overdose crisis Drug benefit plan managers and sponsors often overlook pharmacistsAt the 2017 drug benefits summit, Mark Rolnick of Shoppers Drug Mart suggested opportunities are being missed Health Canada’s OTC codeine ban is a Band-Aid solution We want to expand the scope of pharmacists to take the burden off physicians and ERs, but this ban is a move in the opposite direction Pay incentives for doctors don't improve follow-up rates for patients discharged from hospital Pharmacists lobby Ontario to establish $75 consultation for opioid management If prescription rates remain consistent with the previous year, the program could cost upwards of $150 million Pharmacare could save Canada over $4 billion a year in drug costs A new report from the Parliamentary Budget Officer comes a year after a House of Commons Standing Committee asked for a cost estimate Ontario to cover HIV prevention drug under public health plan The brand name Truvada costs about $1,000 a month but new products are hitting the market at a quarter of that cost How to address the opioid crisis? Invest in 'social capital' Tresiba (insulin degludec): third basal insulin analogue in Canada Glucose-lowering effect of ultralong-acting basal insulin lasts for more than 42 hours Ontario to require disclosure of pharma payments to health professionals First Previous 1141 1142 1143 1144 1145 Next Last
